Signa Sa De Cv, based in Mexico, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CLOPIDOGREL BISULFATE USP, with a corresponding US DMF Number 38695.
Remarkably, this DMF maintains an Active status since its submission on October 27, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 14, 2023, and payment made on November 07, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II